SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) August 29, 2000
BICO, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
2275 Swallow Hill Road, Bldg. 2500, Pittsburgh,
Pennsylvania 15220
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code (412) 429-0673
_________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
BICO, Inc. subsidiary, ViaCirQ, Inc., a leading
developer of extracorporeal hyperthermia medical
devices, announced today that it has entered into
a three-year agreement with North Carolina Baptist
Hospitals, Incorporated to provide Wake Forest
University Baptist Medical Center with the
ThermoChem-HT System and disposable ThermoChem-HT
System packs for all intraperitoneal hyperthermia
procedures.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information and Exhibits.
(a) Financial Statements and Businesses Acquired - Not Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to
be signed on its behalf by the undersigned hereunto duly
authorized.
BICO, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: August 29, 2000
BICO SUBSIDIARY, VIACIRQ, INC., RECEIVES
CONTRACT FOR THERMOCHEM-HT SYSTEM
Pittsburgh, PA - August 29, 2000 - BICO, Inc.
(OTCBB:BICO) subsidiary, ViaCirQ, Inc., a leading developer
of extracorporeal hyperthermia medical devices, announced
today that it has entered into a three-year agreement with
North Carolina Baptist Hospitals, Incorporated to provide
Wake Forest University Baptist Medical Center with the
ThermoChem-HT System and disposable ThermoChem-HT System
packs for all intraperitoneal hyperthermia procedures.
ViaCirQ will realize significant revenue from this contract,
although the exact amount is not known at this time.
Intraperitoneal hyperthermia is used as an adjunctive
therapy with surgery and chemotherapy to treat patients with
peritoneal carcinomatosis (advanced cancer of the abdomen).
This treatment is extending life for many who have few, if
any, options remaining.
ViaCirQ received FDA clearance to market the ThermoChem-
HT System to raise the core temperature of the abdominal
cavity to the desired targeted temperature in the 41C
(105.8F) to 42C (107.6F) range by continuously lavaging the
abdomen with circulating sterile solution. Studies have
shown that heating of the abdominal cavity can make the area
more receptive to adjunctive therapies physicians might
choose, such as chemotherapy.
The treatment was developed clinically by Wake Forest
University Baptist Medical Center and is now offered as a
standard-of-care for treating advanced abdominal cancer.
Five-year data shows patients undergoing this treatment live
longer and have a better quality of life.
A major research center, Wake Forest University Baptist
Medical Center provides many of the latest treatments to
patients and leads the way in researching new and promising
therapies of tomorrow. The ThermoChem-HT System is
manufactured by Biocontrol Technology, Inc., a BICO division
which is an FDA registered manufacturer and an ISO
9001/EN46001 certified manufacturing facility located in
Indiana, PA.
BICO, Inc. has its corporate offices in Pittsburgh, PA
and is involved in the development and manufacture of
biomedical devices and environmental products. BICO's
subsidiary, ViaCirQ, Inc., also located in Pittsburgh, PA,
holds exclusive worldwide marketing rights to the ThermoChem-
HT System and related disposables for regional hyperthermia
and the ThermoChem System and related disposables for whole
body hyperthermia.
FOR FURTHER INFORMATION, CONTACT:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
WEBSITE: www.bico.com